Post Profile

Cancer Treatment as a Double-Edged Sword

Findings by cancer researchers at the Technion-Israel Institute of Technology shed light on why treated cancers recur. The discovery could provide the key for reducing recurrence, and allow anti-cancer drugs to do their intended wor...
read more


Related Posts

Study Uncovers Role Of Gene In Renal Cancers That Don't Respond To Current Therapies But Could Be Helped By Existing FDA-Approved Drug

Health : Medical News Today

Oregon Health & Science University Knight Cancer Institute researchers uncovered a gene that may be the key to helping kidney cancer patients who don't respond to current therapies. This discovery could also provide a toolkit to ide...

Breast cancer drugs may be used to treat lung cancer

Health : Medical News Today

Scientists have discovered that experimental drugs developed as treatments of ovarian and breast cancer could be used to treat lung cancer, according to a study published in the journal Oncogene. Researchers from The Institute of Ca...

Discovery by NUS Researchers Contributes to Better Understanding of Acquired Resistance to Combination Drug Treatment in Cancer

Health : Newswise Medical News

A study on acquired resistance (AQR) to combination drug treatment in cancer, led by scientists from the Cancer Science Institute of Singapore at the National University of Singapore, found that the mechanisms of AQR for the combina...

Cancer Research Technology, The ICR And ZoBio BV Sign Deal To Develop Cancer Drugs

Health : Medical News Today

Cancer Research Technology (CRT) and The Institute of Cancer Research (ICR) have signed a deal with Dutch drug discovery company, ZoBio BV, to discover and develop drugs to block a DNA repair target which may play a role in cancer c...

Trial To Treat Recurrent Brain Cancer Launched By Cancer Research UK

Health : Medical News Today

For the treatment of patients with brain cancer, Cancer Research UK's Drug Development Office has opened up a new trial to investigate a new combination of drugs. The Phase I clinical trial will take place at The Beatson West of Sco...


Copyright © 2016 Regator, LLC